A dedicated team of vascular consultants and nurses have created a new clinical pathway and campaign on leg ulcer treatment. The Leg Ulcer Pathway Audit uses a new treatment pathway, including a vascular referrals process, in the management of new, existing and recurring leg ulcer patients. The two year programme has revealed remarkable clinical results for patients.

The Leg ulcer pathway launch event, supported by Boston Scientific, will examine the clinical, health and economic impacts of the pathway, as well as hearing from patient representatives on the impact of the new leg ulcer pathway.

For details, please contact Daniel Malynn.